Investigating genetic factors that influence prostate cancer risk in diverse populations.
Germline Genetics and Risk of Prostate Cancer in Diverse Populations from the All of Us Program
This study is looking at how genes might affect the risk of prostate cancer, especially in different groups of people like African American and Asian men, and it will also consider how things like lifestyle and environment play a role; if you join, you might get genetic testing to help understand your own risk and contribute to important research for preventing cancer in the future.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10931627 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetic factors contribute to the risk of prostate cancer, particularly in diverse populations, including African American and Asian individuals. By analyzing both common and rare genetic variants, the study aims to develop a more comprehensive understanding of prostate cancer risk. The research will also consider how lifestyle, environmental, and socioeconomic factors interact with genetic predispositions. Participants may undergo genetic testing to identify their risk levels and contribute to a larger database that can inform future cancer prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation include men of African American and Asian descent who are concerned about their prostate cancer risk.
Not a fit: Patients who do not have a family history of prostate cancer or those who are not of African or Asian descent may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved risk assessment and personalized prevention strategies for prostate cancer in diverse populations.
How similar studies have performed: Previous research has shown success in identifying genetic risk factors for prostate cancer, but this study aims to expand knowledge specifically in underrepresented populations.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Darst, Burcu Frances — Fred Hutchinson Cancer Center
- Study coordinator: Darst, Burcu Frances
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.